Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 569

1.

Mechanisms of penile fibrosis.

Gonzalez-Cadavid NF.

J Sex Med. 2009 Mar;6 Suppl 3:353-62. doi: 10.1111/j.1743-6109.2008.01195.x. Review.

PMID:
19267860
[PubMed - indexed for MEDLINE]
2.

Molecular pathophysiology and gene therapy of aging-related erectile dysfunction.

Gonzalez-Cadavid NF, Rajfer J.

Exp Gerontol. 2004 Nov-Dec;39(11-12):1705-12. Review.

PMID:
15582286
[PubMed - indexed for MEDLINE]
3.

Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.

Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, Gonzalez-Cadavid NF.

Nitric Oxide. 2002 Dec;7(4):262-76.

PMID:
12446175
[PubMed - indexed for MEDLINE]
4.

Experimental models of Peyronie's disease. Implications for new therapies.

Gonzalez-Cadavid NF, Rajfer J.

J Sex Med. 2009 Feb;6(2):303-13. doi: 10.1111/j.1743-6109.2008.01104.x. Epub 2008 Dec 2. Review.

PMID:
19138365
[PubMed - indexed for MEDLINE]
5.

Profibrotic role of myostatin in Peyronie's disease.

Cantini LP, Ferrini MG, Vernet D, Magee TR, Qian A, Gelfand RA, Rajfer J, Gonzalez-Cadavid NF.

J Sex Med. 2008 Jul;5(7):1607-22. doi: 10.1111/j.1743-6109.2008.00847.x.

PMID:
18422491
[PubMed - indexed for MEDLINE]
6.

Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Gonzalez-Cadavid NF, Rajfer J.

Nat Rev Urol. 2010 Apr;7(4):215-21. doi: 10.1038/nrurol.2010.24. Epub 2010 Mar 9. Review.

PMID:
20212516
[PubMed - indexed for MEDLINE]
7.

Vasculogenic erectile dysfunction: newer therapeutic strategies.

Siroky MB, Azadzoi KM.

J Urol. 2003 Aug;170(2 Pt 2):S24-9; discussion S29-30. Review.

PMID:
12853769
[PubMed - indexed for MEDLINE]
8.

Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease.

Gonzalez-Cadavid NF, Rajfer J.

Nat Clin Pract Urol. 2005 Jun;2(6):291-7. Review.

PMID:
16474811
[PubMed - indexed for MEDLINE]
9.

Penile duplex ultrasonography in men with Peyronie's disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?

Chung E, De Young L, Brock GB.

J Sex Med. 2011 Dec;8(12):3446-51. doi: 10.1111/j.1743-6109.2011.02501.x. Epub 2011 Oct 7.

PMID:
21981553
[PubMed - indexed for MEDLINE]
10.

Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.

Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, Gonzalez-Cadavid NF.

Biol Reprod. 2007 May;76(5):915-23. Epub 2007 Feb 7.

PMID:
17287493
[PubMed - indexed for MEDLINE]
Free Article
11.

Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media.

Ferrini MG, Davila HH, Valente EG, Gonzalez-Cadavid NF, Rajfer J.

Cardiovasc Res. 2004 Mar 1;61(4):796-805.

PMID:
14985077
[PubMed - indexed for MEDLINE]
Free Article
12.

Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction.

Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D, Rajfer J, Gonzalez-Cadavid NF.

BJU Int. 2009 May;103(10):1396-404. doi: 10.1111/j.1464-410X.2008.08251.x. Epub 2009 Jan 19.

PMID:
19154511
[PubMed - indexed for MEDLINE]
13.

Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study.

Usta MF, Bivalacqua TJ, Tokatli Z, Rivera F, Gulkesen KH, Sikka SC, Hellstrom WJ.

J Urol. 2004 Jul;172(1):259-62.

PMID:
15201789
[PubMed - indexed for MEDLINE]
14.

Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.

Davila HH, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF.

Biol Reprod. 2004 Nov;71(5):1568-77. Epub 2004 Jul 7.

PMID:
15240426
[PubMed - indexed for MEDLINE]
Free Article
15.

Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease.

Bivalacqua TJ, Champion HC, Hellstrom WJ.

Int J Impot Res. 2002 Oct;14(5):345-52. Review.

PMID:
12454685
[PubMed - indexed for MEDLINE]
Free Article
16.

Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats.

Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N.

Int J Impot Res. 2008 Mar-Apr;20(2):202-12. Epub 2007 Sep 20.

PMID:
17882231
[PubMed - indexed for MEDLINE]
17.

[Modern aspects of pathophysiology and prevention of erectile dysfunction and cavernous fibrosis after radical prostatectomy].

Veliev EI, Vanin AF, Kotov SV, Shiahlo VK.

Urologiia. 2009 Mar-Apr;(2):46-51. Russian.

PMID:
19526874
[PubMed - indexed for MEDLINE]
18.

Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.

Paulis G, Brancato T.

Inflamm Allergy Drug Targets. 2012 Feb;11(1):48-57. Review.

PMID:
22309083
[PubMed - indexed for MEDLINE]
19.

Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.

Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF.

Urology. 2004 Aug;64(2):399-404.

PMID:
15302515
[PubMed - indexed for MEDLINE]
20.

Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease.

Davila HH, Ferrini MG, Rajfer J, Gonzalez-Cadavid NF.

BJU Int. 2003 Jun;91(9):830-8.

PMID:
12780843
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk